Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables ...
Nuclear Imaging
Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.
July 25, 2016 — UltraSPECT Inc. announced recently that Robert Wood Johnson Physician Enterprise (RWJPE), a multi ...
Making healthcare more objective and precise promises to increase efficiency and reduce costs — the key ingredients of ...
Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...
July 19, 2016 - An updated joint American Society of Nuclear Cardiology (ASNC) imaging guidelines and Society of Nuclear ...
July 14, 2016 — Adding F-18-choline positron emission tomography (PET) to multi-parametric prostate magnetic resonance ...
July 12, 2016 — Lantheus Holdings Inc., the parent company of Lantheus Medical Imaging Inc. (LMI), announced the first ...
July 7, 2016 — Cell>Point announced in mid-June it has entered into an exclusive license agreement for China, Hong Kong ...
Mammography may be the most recognizable — and singularly effective — type of personalized medicine, benefitting from ...
July 6, 2016 — Navidea Biopharmaceuticals Inc. announced results from three investigator-initiated studies of the ...
June 29, 2016 — Hodgkin lymphoma patients can be spared the serious side effects of chemotherapy thanks to high-tech ...
June 27, 2016 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has been named a qualified provider-led ...
June 24, 2016 — Developers of a new portable molecular imaging system debuted their creation at the 2016 Annual Meeting ...
June 23, 2016 — Cancer patients often experience significant fluctuations in weight and lean body mass (LBM). Neglecting ...
June 23, 2016 — Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and ...
June 23, 2016 — The triggers of autoimmune inflammation in multiple sclerosis (MS) have eluded scientists for many years ...
June 23, 2016 — Aggressive neuroendocrine cancer is something of a dark horse — a rare, elusive and persevering force ...
June 22, 2016 — Non-small cell lung cancers (NSCLC) have a collective reputation for not responding very well to ...
June 21, 2016 — Preliminary tests have demonstrated that a new device may enable up to six times better contrast of ...
June 20, 2016 — Prostate cancer is the leading cancer among men, second only to skin cancer. With surgical removal at ...
June 20, 2016 — An emerging cancer therapy has colorectal tumors surrounded. Presenters at the 2016 Annual Meeting of ...